A mouse model of Clostridium difficile-associated disease. - Wikidata - wikimedia - TriplyDB

A mouse model of Clostridium difficile-associated disease.

A mouse model of Clostridium difficile-associated disease.

http://www.wikidata.org/entity/Q34598259

about

Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins Interactions Between the Gastrointestinal Microbiome and Clostridium difficile Murine models to study Clostridium difficile infection and transmission Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches Fate of ingested Clostridium difficile spores in mice IL-22 Restrains Tapeworm-Mediated Protection against Experimental Colitis via Regulation of IL-25 Expression Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria Metabolism of bile salts in mice influences spore germination in Clostridium difficile The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.The microbiota and immune response during Clostridium difficile infection.Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea.Role of interleukin 23 signaling in Clostridium difficile colitis Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model.Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection.Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.Clostridium difficile flagella induce a pro-inflammatory response in intestinal epithelium of mice in cooperation with toxins Equine hyperimmune serum protects mice against Clostridium difficile spore challenge Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.Regulation of the gut microbiota by the mucosal immune system in mice.

P2860

Q24616179-E795C2FE-4427-4741-83CE-6AAE2F0BC084 Q24633338-1D29AA7C-B9E9-4F3A-952E-C4EF5FD56CEB Q26778722-B92D724A-064A-4909-AB35-2260B89D7721 Q26859965-BDCCC124-9049-46CD-B7DC-C8AB14203ADD Q26995670-F9991BF6-FCA5-424A-8BF7-BD698EABC86D Q27012682-32B3286B-B812-4F79-8BAC-2ABF85251175 Q27308882-F18EA2DE-38C7-4AA6-9B0F-D7CC7DF2B620 Q27315163-289BBF09-9BD4-4012-BE96-77DBE2D9CF2B Q27316166-5D0808EB-48A1-43A1-A89D-CFF006202439 Q28472543-6A8CFF0A-0685-4230-A3CD-EDC174E7E5C2 Q30276036-403AE511-CC1A-4B6E-842A-E9A198B005DE Q30276498-3925C7E9-A3A8-428A-931C-14AB3F1CC443 Q30276756-2A9AAC79-A3F6-4F86-9BA7-EA7D285FE8DD Q30277264-56DAB691-C2E0-442F-85BB-35F9A5AA40B3 Q30279007-D183537C-E175-4F25-B8C1-15699303FAF0 Q30301156-D196F4CB-8F75-4D9A-BF68-24ADDF7911B2 Q30410725-B298B2CA-9815-49F3-AE3C-2247E844A65E Q30412148-A05B8297-1A01-4BC0-A8CE-8570B5AB2CED Q30413086-2D8D7976-CE69-44DC-A416-4A45AEF6F49E Q30416554-FB388E3C-5A55-4E22-AAC3-4A1A62C0F636 Q30417830-CBFA288E-6560-471E-9C38-87A4A0B93D15 Q30419035-89B2842F-CF07-46BB-BB74-9D2DF74AC97A Q30423298-6919FC92-0A0D-4C3C-94CF-9B012E7FD076 Q30424551-99289263-31EA-4184-ACA0-9B34968D6435 Q30429490-1FE88F60-E94E-40F1-9BCB-C1A38AD25332 Q30834661-20FC4468-4FD9-4676-B3EF-DA7833EDA02F Q33420665-9D646482-CDE8-4730-B17C-E8999349298E Q33586133-21B0371D-D710-45AD-A584-217AB013146A Q33609732-305BE039-4D81-4F37-B3D7-B2713AF67215 Q33641301-7F8F0CB7-C67D-48EF-AEAE-DBF511F29FF9 Q33686153-01B54090-37FD-47F0-9415-D73D4A27E056 Q33728333-7AA35535-5063-4DDA-91A3-E700405FA192 Q33789667-0CA84902-79F7-448E-AA16-603421BFB9C5 Q33865434-6E9F3E85-99E2-42C1-B353-784D60AA9450 Q33880455-A19C5B0B-14CA-405C-8E91-9E9B7C71F267 Q33896435-07BC7DF9-56D6-4B92-A0AD-659FC5A4C0D1 Q33899721-48822F30-157E-4617-9CBC-7D6597FBC2F1 Q33954369-A8B0895B-6EFA-40A1-803E-E25986DA2866 Q34044442-8FEBA660-BB66-469D-85ED-E154F8EA3CFA Q34081385-464E3FB8-32A3-4194-8AFD-EC0DF268E4FC

P2860

A mouse model of Clostridium difficile-associated disease.

http://www.wikidata.org/entity/Q34598259

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

A mouse model of Clostridium difficile-associated disease.

@ast

A mouse model of Clostridium difficile-associated disease.

@en

A mouse model of Clostridium difficile-associated disease.

@nl

type

label

A mouse model of Clostridium difficile-associated disease.

@ast

A mouse model of Clostridium difficile-associated disease.

@en

A mouse model of Clostridium difficile-associated disease.

@nl

prefLabel

A mouse model of Clostridium difficile-associated disease.

@ast

A mouse model of Clostridium difficile-associated disease.

@en

A mouse model of Clostridium difficile-associated disease.

@nl

P1433

Q34598259-02D4971C-0D2A-4690-9FD7-A87C393BB18E

P1476

Q34598259-7D060C74-3C91-46E5-AE4A-13C6B58AD4BE

P2093

Q34598259-3974D628-4C8C-43A7-B634-27C86269DFD4

Q34598259-82F7D0CB-1968-4493-84F6-ECD99A56FE2E

Q34598259-9B31DD5F-168E-4E9D-94E9-B23B45300DCD

Q34598259-A04A7E12-0E52-4635-839C-A7F125AA1497

Q34598259-DBEE99C7-51BD-4304-BFFC-A2EA13B00FF8

Q34598259-F757BC04-2C33-4A1F-B4B2-26A400705EB5

P304

Q34598259-AE22E6D1-5FBA-4485-B7F3-EE9E96292C39

P31

Q34598259-F1B88CD6-4C01-4458-B331-449EEFABFA10

P356

Q34598259-228F4FF4-5E28-46C7-9527-04F6F33EB93B

P407

Q34598259-5019F0E4-A4CA-4892-AB14-FBC250B9766C

P433

Q34598259-B0831A19-75B3-4887-B2EB-84F3EBBB6E61

P478

Q34598259-556B7BC6-3296-45E6-AAD2-A9D9E2730A96

P50

Q34598259-FF918480-0F63-4704-ABDA-90DB19EEA64D

P577

Q34598259-D461A508-6EF7-47BB-9EE5-62280CCE2D27

P5875

Q34598259-2BD3C808-1017-4126-BF0E-13793EA1839B

P698

Q34598259-C70F7EDA-059E-412A-A9E0-9197A023B8CB

P921

Q34598259-B9589D75-47D3-405A-A52E-A0947542933B

P356

J.GASTRO.2008.09.002

P1433

Gastroenterology

P1476

A mouse model of Clostridium difficile-associated disease.

@en

P2093

Adam Cheknis

http://www.w3.org/2001/XMLSchema#string

Ciarán P Kelly

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Goldsmith

http://www.w3.org/2001/XMLSchema#string

Kianoosh Katchar

http://www.w3.org/2001/XMLSchema#string

Nanda Nanthakumar

http://www.w3.org/2001/XMLSchema#string

Xinhua Chen

http://www.w3.org/2001/XMLSchema#string

P304

1984-1992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2008.09.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23313515

http://www.w3.org/2001/XMLSchema#string

P698

18848941

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile